More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$5.29B
EPS
1.57
P/E ratio
89.9
Price to sales
5.19
Dividend yield
--
Beta
1.724332
Previous close
$135.59
Today's open
$137.73
Day's range
$137.43 - $141.19
52 week range
$98.27 - $176.38
show more
CEO
Matthijs Glastra
Employees
3000
Headquarters
Bedford, MA
Exchange
Nasdaq Global Select
Shares outstanding
37817770
Issue type
Common Stock
Technology
Hardware & Equipment
Human Data, Robot Hands: Where Automation Goes Next
High-quality real-world data has been a major bottleneck for teaching robot hands: A video can show movement without measuring touch or force.
ETF Trends • Oct 21, 2026

Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that giv.
Business Wire • Oct 20, 2026

How to Invest in AI Drug Discovery
.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.
ETF Trends • Oct 14, 2026

Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conf.
Business Wire • Oct 13, 2026

How to Build a Humanoid Body
Last month we broke down the three key areas needed to build your own humanoid. We have already looked at the companies behind the technologies required to build a humanoid's brain.
ETF Trends • Sep 16, 2026

Are Robots the New Normal? Bet on these ETFs to Invest in the Future
Robotics is entering a new era as AI fuels humanoid adoption, with four ETFs offering diversified exposure to the sector's growth.
Zacks Investment Research • Sep 4, 2026

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical a.
Business Wire • Aug 28, 2026

How to Build a Humanoid Brain
In our previous guide to building a humanoid robot, we mapped out the three essential pillars of the project: the brain, the body, and the energy systems. Now, it is time to look closer at the brain.
ETF Trends • Aug 19, 2026

Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Zacks Investment Research • Aug 18, 2026

Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice
Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Aug 12, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Novanta Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.